 Gur Pines
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mutagenesis | 5 | 2025 | 192 | 1.570 |
Why?
| | CRISPR-Cas Systems | 5 | 2025 | 170 | 1.270 |
Why?
| | Aldose-Ketose Isomerases | 2 | 2020 | 8 | 1.220 |
Why?
| | Directed Molecular Evolution | 2 | 2020 | 29 | 1.150 |
Why?
| | Drug Resistance | 2 | 2020 | 153 | 1.150 |
Why?
| | Codon | 3 | 2018 | 94 | 1.060 |
Why?
| | Genetic Engineering | 4 | 2018 | 93 | 0.790 |
Why?
| | Fosfomycin | 2 | 2020 | 2 | 0.740 |
Why?
| | Nuclear Family | 1 | 2022 | 52 | 0.740 |
Why?
| | Genetic Code | 2 | 2017 | 25 | 0.660 |
Why?
| | Malaria | 2 | 2026 | 74 | 0.650 |
Why?
| | Synthetic Biology | 2 | 2017 | 16 | 0.640 |
Why?
| | Antimalarials | 1 | 2018 | 35 | 0.570 |
Why?
| | ErbB Receptors | 6 | 2018 | 630 | 0.550 |
Why?
| | Point Mutation | 1 | 2017 | 243 | 0.490 |
Why?
| | Insect Proteins | 2 | 2026 | 41 | 0.460 |
Why?
| | Gene Library | 5 | 2020 | 126 | 0.450 |
Why?
| | Homologous Recombination | 1 | 2015 | 36 | 0.440 |
Why?
| | Mutation | 8 | 2020 | 4104 | 0.440 |
Why?
| | Bacteriophage lambda | 1 | 2015 | 90 | 0.420 |
Why?
| | Escherichia coli | 5 | 2020 | 855 | 0.410 |
Why?
| | Oncogene Proteins v-erbB | 1 | 2012 | 3 | 0.370 |
Why?
| | Protein Engineering | 4 | 2018 | 123 | 0.360 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2012 | 339 | 0.350 |
Why?
| | Genes, erbB-1 | 1 | 2010 | 21 | 0.320 |
Why?
| | Neoplasms | 4 | 2016 | 2887 | 0.300 |
Why?
| | Plasmodium falciparum | 2 | 2020 | 39 | 0.300 |
Why?
| | Bacteria | 1 | 2015 | 891 | 0.280 |
Why?
| | Glioblastoma | 1 | 2010 | 354 | 0.250 |
Why?
| | Signal Transduction | 5 | 2012 | 5239 | 0.250 |
Why?
| | Anopheles | 1 | 2026 | 18 | 0.240 |
Why?
| | Algorithms | 5 | 2018 | 1846 | 0.240 |
Why?
| | Mosquito Vectors | 1 | 2026 | 29 | 0.240 |
Why?
| | Plant Viruses | 1 | 2025 | 12 | 0.230 |
Why?
| | Crops, Agricultural | 1 | 2025 | 31 | 0.230 |
Why?
| | Luminescent Proteins | 1 | 2026 | 186 | 0.230 |
Why?
| | Tephritidae | 1 | 2025 | 18 | 0.230 |
Why?
| | Longevity | 1 | 2026 | 174 | 0.220 |
Why?
| | Epidermal Growth Factor | 2 | 2018 | 172 | 0.210 |
Why?
| | RNA Viruses | 1 | 2025 | 76 | 0.210 |
Why?
| | Gene Editing | 3 | 2025 | 93 | 0.210 |
Why?
| | Amino Acids | 3 | 2018 | 522 | 0.200 |
Why?
| | Weightlessness | 1 | 2023 | 39 | 0.190 |
Why?
| | Acari | 1 | 2022 | 2 | 0.180 |
Why?
| | Australia | 1 | 2022 | 287 | 0.170 |
Why?
| | Europe | 1 | 2022 | 416 | 0.170 |
Why?
| | Biosensing Techniques | 1 | 2023 | 139 | 0.170 |
Why?
| | Antineoplastic Agents | 1 | 2012 | 2202 | 0.160 |
Why?
| | Brain Neoplasms | 1 | 2010 | 1327 | 0.160 |
Why?
| | Plasmids | 2 | 2018 | 379 | 0.160 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 35 | 0.140 |
Why?
| | Non-Fibrillar Collagens | 1 | 2018 | 3 | 0.140 |
Why?
| | Data Compression | 1 | 2018 | 8 | 0.140 |
Why?
| | Filamins | 1 | 2018 | 28 | 0.130 |
Why?
| | Actin Cytoskeleton | 1 | 2018 | 103 | 0.130 |
Why?
| | Breast | 1 | 2018 | 159 | 0.130 |
Why?
| | Metabolic Engineering | 1 | 2016 | 36 | 0.120 |
Why?
| | DNA Mutational Analysis | 1 | 2016 | 409 | 0.110 |
Why?
| | Chromosome Mapping | 1 | 2016 | 510 | 0.110 |
Why?
| | Saccharomyces cerevisiae | 1 | 2020 | 579 | 0.110 |
Why?
| | Models, Genetic | 1 | 2017 | 536 | 0.110 |
Why?
| | Autoantigens | 1 | 2018 | 429 | 0.110 |
Why?
| | Oligonucleotides | 1 | 2014 | 151 | 0.100 |
Why?
| | Mice, Nude | 2 | 2018 | 688 | 0.100 |
Why?
| | Immunoprecipitation | 2 | 2010 | 151 | 0.090 |
Why?
| | Early Growth Response Protein 1 | 1 | 2011 | 32 | 0.090 |
Why?
| | Cell Movement | 2 | 2018 | 965 | 0.090 |
Why?
| | Systems Biology | 1 | 2012 | 72 | 0.090 |
Why?
| | Endopeptidases | 1 | 2011 | 82 | 0.090 |
Why?
| | Mammary Glands, Human | 1 | 2011 | 67 | 0.090 |
Why?
| | Drug Discovery | 1 | 2012 | 155 | 0.080 |
Why?
| | Ubiquitin | 2 | 2011 | 86 | 0.080 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 173 | 0.080 |
Why?
| | Genome, Bacterial | 3 | 2017 | 157 | 0.080 |
Why?
| | Genomics | 3 | 2023 | 842 | 0.080 |
Why?
| | Proteomics | 1 | 2018 | 1195 | 0.080 |
Why?
| | Phosphotransferases | 1 | 2010 | 27 | 0.080 |
Why?
| | Peptides | 1 | 2016 | 999 | 0.080 |
Why?
| | Animals | 7 | 2026 | 38177 | 0.080 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2012 | 230 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2018 | 2506 | 0.080 |
Why?
| | Databases, Factual | 1 | 2016 | 1488 | 0.080 |
Why?
| | Receptor, ErbB-3 | 1 | 2010 | 48 | 0.080 |
Why?
| | NIH 3T3 Cells | 1 | 2010 | 148 | 0.080 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2010 | 47 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2016 | 1169 | 0.080 |
Why?
| | Genetic Variation | 1 | 2015 | 986 | 0.080 |
Why?
| | Oncogenes | 1 | 2010 | 119 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2020 | 1922 | 0.070 |
Why?
| | Medical Oncology | 1 | 2012 | 332 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2152 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2016 | 3560 | 0.070 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2017 | 550 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2011 | 437 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 675 | 0.070 |
Why?
| | Mass Spectrometry | 1 | 2010 | 750 | 0.060 |
Why?
| | Phosphorylation | 3 | 2018 | 1735 | 0.060 |
Why?
| | Lysosomes | 1 | 2007 | 128 | 0.060 |
Why?
| | Brassica napus | 1 | 2025 | 2 | 0.060 |
Why?
| | Cucumis sativus | 1 | 2025 | 6 | 0.060 |
Why?
| | CRISPR-Associated Proteins | 1 | 2025 | 3 | 0.060 |
Why?
| | Plant Diseases | 1 | 2025 | 44 | 0.060 |
Why?
| | Animals, Genetically Modified | 1 | 2026 | 251 | 0.060 |
Why?
| | Genetic Markers | 1 | 2026 | 332 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2464 | 0.050 |
Why?
| | Recombinases | 1 | 2023 | 8 | 0.050 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 974 | 0.050 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2023 | 39 | 0.050 |
Why?
| | Astronauts | 1 | 2023 | 30 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2010 | 1525 | 0.050 |
Why?
| | Models, Biological | 1 | 2010 | 1823 | 0.050 |
Why?
| | Dimerization | 2 | 2016 | 194 | 0.050 |
Why?
| | Humans | 10 | 2023 | 145305 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2026 | 1260 | 0.040 |
Why?
| | Genotype | 2 | 2017 | 1845 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2026 | 692 | 0.040 |
Why?
| | Proteome | 2 | 2016 | 518 | 0.040 |
Why?
| | Ubiquitination | 2 | 2011 | 118 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2010 | 381 | 0.030 |
Why?
| | Mice | 2 | 2018 | 18394 | 0.030 |
Why?
| | Isotope Labeling | 1 | 2018 | 83 | 0.030 |
Why?
| | Ecosystem | 1 | 2022 | 590 | 0.030 |
Why?
| | Genome, Fungal | 1 | 2016 | 42 | 0.030 |
Why?
| | Osmotic Pressure | 1 | 2016 | 39 | 0.030 |
Why?
| | Adaptation, Biological | 1 | 2016 | 52 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2016 | 66 | 0.030 |
Why?
| | Nucleotides | 1 | 2016 | 129 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 396 | 0.030 |
Why?
| | Female | 4 | 2026 | 78605 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2016 | 199 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1048 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2018 | 931 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 824 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2652 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2015 | 373 | 0.020 |
Why?
| | Metabolome | 1 | 2016 | 385 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2016 | 2158 | 0.020 |
Why?
| | Two-Hybrid System Techniques | 1 | 2011 | 59 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1992 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2011 | 117 | 0.020 |
Why?
| | Single-Cell Analysis | 1 | 2015 | 359 | 0.020 |
Why?
| | Protein Binding | 1 | 2018 | 2283 | 0.020 |
Why?
| | Software | 1 | 2016 | 692 | 0.020 |
Why?
| | Catalysis | 1 | 2011 | 322 | 0.020 |
Why?
| | Machine Learning | 1 | 2016 | 589 | 0.020 |
Why?
| | Cricetulus | 1 | 2010 | 118 | 0.020 |
Why?
| | CHO Cells | 1 | 2010 | 171 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2018 | 4155 | 0.020 |
Why?
| | Cricetinae | 1 | 2010 | 304 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 635 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2010 | 214 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2010 | 178 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3419 | 0.020 |
Why?
| | Male | 2 | 2026 | 72628 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2010 | 862 | 0.020 |
Why?
| | Phenotype | 1 | 2016 | 3172 | 0.020 |
Why?
| | Biotinylation | 1 | 2007 | 37 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2007 | 13 | 0.020 |
Why?
| | Immunoblotting | 1 | 2007 | 300 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2882 | 0.010 |
Why?
| | STAT3 Transcription Factor | 1 | 2007 | 207 | 0.010 |
Why?
| | MicroRNAs | 1 | 2011 | 701 | 0.010 |
Why?
| | Down-Regulation | 1 | 2007 | 627 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1787 | 0.010 |
Why?
| | Disease Progression | 1 | 2011 | 2855 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1496 | 0.010 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 1183 | 0.010 |
Why?
|
|
Pines's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|